BackProvectus Biopharmaceuticals Overview

Provectus Biopharmaceuticals Minority Interest

Provectus Biopharmaceuticals's minority interest is $-12K.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$-12393.00
↑ 223.58% YoYΔ $-8563.00 vs prior year quarter

Peer trimmed avg / median

Loading

Provectus Biopharmaceuticals Minority Interest History

Loading

Provectus Biopharmaceuticals vs. peers: Minority Interest Comparison

Loading

Provectus Biopharmaceuticals Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Provectus Biopharmaceuticals (PVCT) FAQ

As of the most recent data (June 2026), PVCT shows a minority interest of $-12K. That compares with $-3.8K in the prior-year period — down 223.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PVCT's minority interest is now $-12K (was $-3.8K) — a 223.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Provectus Biopharmaceuticals is outperforming or lagging.

Tracking PVCT's minority interest over time shows whether Provectus Biopharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $-12K That compares with $-3.8K in the prior-year period — down 223.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Provectus Biopharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-12K) with ownership activity and broader fundamentals.

Provectus Biopharmaceuticals's minority interest is $-12K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.